President’s Message

Dear Friends,

At SHENTEK, our mission is simple: to make biologics quality control safer, faster, and more reliable. As the biopharmaceutical industry advances, tomorrow’s therapies—from biologics and regenerative medicine products to cell and gene therapies—demand innovative solutions that ensure the highest standards of safety, quality, and regulatory compliance.

We support our partners at every stage of development, from early research to clinical trials and product commercialization. Our standardized QC products and tailored analytical solutions are designed to meet the unique needs of different cell types, manufacturing platforms, and regulatory environments. Over the years, SHENTEK has proudly partnered with thousands of customers worldwide, helping them navigate complex analytical and quality challenges.

At SHENTEK, quality is more than a process—it’s a mindset. We emphasize early integration of robust quality strategies, especially for breakthrough therapies emerging from academic or early-stage ventures, helping partners mitigate risks before they arise.

As an ISO 13485-certified company, we are committed to continuous innovation. Our highly sensitive assays and QC platforms are developed with global regulatory compliance in mind, enabling reliable results and faster development timelines.

I am proud of what we achieve at SHENTEK, but the greatest reward is seeing scientific innovation translate into therapies that improve patients’ lives. Together with our partners, we are building a strong foundation for advanced therapies—ensuring a future of medicine that is safe, high-quality, and accessible.

— Tao Wang, Ph.D, President

Company